Results 311 to 320 of about 14,670,208 (357)
Some of the next articles are maybe not open access.

Therapeutic Drug Monitoring of Antiarrhythmic Drugs

Clinical Pharmacokinetics, 2003
Most antiarrhythmic drugs fulfil the formal requirements for rational use of therapeutic drug monitoring, as they show highly variable plasma concentration profiles at a given dose and a direct concentration-effect relationship. Therapeutic ranges for antiarrhythmic drugs are, however, often very poorly defined.
Gesche, Jürgens   +2 more
openaire   +2 more sources

Drug level monitoring of antiasthmatic drugs

Journal of Chromatography B: Biomedical Sciences and Applications, 1985
In general assays pertaining to drug level monitoring (DLM) of antiasthmatic agents (except theophylline), published during the period 1978-1983, used mostly high-performance liquid chromatographic (HPLC) methodology (approximately 45%) with mass spectrometric (MS) based assays in second place (approximately 30%) followed by immunochemical techniques ...
N, Kucharczyk, F H, Segelman
openaire   +2 more sources

Drug monitoring in the elderly

Clinical Biochemistry, 1986
Although the gut changes markedly with age no important differences in drug absorption have yet been demonstrated for any of a wide variety of drugs. Alterations in body structure and function can have important consequences on drug distribution in the elderly.
openaire   +2 more sources

Problems in Therapeutic Drug Monitoring

Therapeutic Drug Monitoring, 1988
Historically, it has been assumed that only free drug concentration is the pharmacologically active species. This article reviews the theoretical pharmacological and pharmacokinetic justifications for monitoring free drug levels. The determinants likely to influence plasma protein binding and the free concentrations of drugs are delineated.
J, Barre   +3 more
openaire   +2 more sources

Therapeutic Drug Monitoring of the Antimycobacterial Drugs

Clinics in Laboratory Medicine, 1996
Because MDR tuberculosis and MAC are difficult to treat, TDM with the antimycobacterial drugs has become the standard of practice at NJC. By combining specific and sensitive assays, carefully collected samples, and clinical expertise, we are able to control and optimize antimycobacterial drug therapy.
openaire   +2 more sources

Advances in drug monitoring and therapeutic drug monitoring

Analytical Proceedings, 1992
David L. Colbert   +4 more
openaire   +1 more source

Antibody–Drug Conjugates: Smart Chemotherapy Delivery Across Tumor Histologies

Ca-A Cancer Journal for Clinicians, 2022
Shanu Modi   +2 more
exaly  

Therapeutic drug monitoring

Clinical Pharmacology and Therapeutics, 1988
R, Spector   +3 more
openaire   +4 more sources

THERAPEUTIC DRUG MONITORING

2021
AZEVEDO PINA VAZ CIDALIA IRENE   +1 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy